project id: TCGA-UCEC; case submitter id: TCGA-BS-A0TD; selected normal wgs: true; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 8.9; spectrophotometer method: UV Spec; age at index: 65; days to birth: -23950; ethnicity: not hispanic or latino; gender: female; race: asian; vital status: Alive; year of birth: 1940; age at diagnosis: 23950; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2379.0; figo stage: Stage IB; icd 10 code: C54.9; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Corpus uteri; synchronous malignancy: No; tissue or organ of origin: Corpus uteri; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2004; days to sample procurement: 0; initial weight: 150.0; portion submitter id: TCGA-BS-A0TD-01A-11; percent lymphocyte infiltration: 40.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;